Here's the kind I like to buy -- and the vetted stocks that you can play on 'good' risk.
ADMA Biologics and Organogenesis Holdings recently issued preliminary year-end 2020 results that were encouraging.
Has WBA rallied too much?
Here are options plays involving promising small-caps Clearside Biomedical and Mustang Bio.
The history we are concerned about is the past couple of weeks.
The technical indicators of the health benefits concern are not sending strong signals at present.
MRNA has corrected its big November rally and now looks ready to start a fresh advance, according to the charts.
Let's check out the charts and technical indicators.
Here's an update on EBS shares.
I do not find enough technical reasons to recommend new long positions at this point in time.